Melanie Joy

Melanie Joy

Associate Professor
Pharmaceutical Sciences
  • Skaggs School of Pharmacy and Pharmaceutical Sciences

Recent Publications

Director of Pharmaceutical Science Innovation and Commercialization

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Fourth Floor Room 4108

Research Interests:

  • In Vivo and In Vitro Drug Metabolism and Transport in Kidney
  • Nephrotoxicity / Biomarkers
  • Pharmacokinetics/Pharmacodynamics/Pharmacogenomics
  • Discovery and Translation of Novel Treatment Approaches to Kidney Diseases

Representative publications:

Ibrahim ME, Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant CL, Bowles DW, George B, Wen X, Buckley B, Aleksunes L, Joy MS. Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients. Eur J Clin Pharmacol. 2018 Sep 15. [Epub ahead of print]. PMID: 30220072.

Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O’Bryant C, Bowles DW, George B, Wen X, Aleksunes LM, Joy MS. Pharmacogenomic variants may influence the urinary excretion of novel kidney injury biomarkers in patients receiving cisplatin. Int J Mol Sci 2017;Jun 22;18(7).